First Class Research
From providing our patients with the most up-to-date diagnostic and treatment options to assisting each in the best care and coping opportunities, we aim to fulfill the needs of the whole patient. Through foundation support and exceptional faculty leadership, the DENT Neurosciences Research Center is able to build upon the philosophy by providing advancement, support and education to our providers and partners.
About the DNRC
The Dent Neuroscience Research Center (DNRC) is a 501(c)(3) not-for-profit affiliate of DENT dedicated to outcomes research and education supported by foundations, industry and personal contributions. The DNRC is focused on developing comprehensive, clinically relevant, and cost effective solutions to complex neurological problems faced in our community.
Building awareness, fostering relationships, providing support and continuous education are at the forefront of the DENT philosophy. From providing our patients with the most up-to-date diagnostic and treatment options to assisting each in the best care and coping opportunities, we aim to fulfill the needs of the whole patient. Through foundation support and exceptional faculty leadership, DNRC is able to build upon the philosophy by providing advancement, support and education to our providers and partners.
Open Studies
Want to participate in a study?
Please call 716-250-2009 and one of our Research Coordinators will be in contact with you as soon as possible. If we currently do not have a study that is currently available for you, we will add you to our database for future studies.
- All
- Alzheimer's
- Behavioral Health
- Epilepsy
- Headache/Migraine
- Multiple Sclerosis
- Parkisons Disease
- Research Study
- Stroke Center
- Treatment-Resistant Depression
- Uncategorized
- All
- Alzheimer's
- Behavioral Health
- Epilepsy
- Headache/Migraine
- Multiple Sclerosis
- Parkisons Disease
- Research Study
- Stroke Center
- Treatment-Resistant Depression
- Uncategorized
Sanofi VITALIZE
EVIDERA EVA-38569-03
TEVA IMPACT TD
ALZ-NET
Migraine prevention injection in patients with unsuccessful prior preventive treatments
Chronic Migraine Implant for Migraine Prevention (RELIEV-CM2)
Menstrual Migraine Prevention
SANOFI EFC17504
PIPELINE/CONTINEUM VISTA
INDIVIOR INDV-6000-406
Jazz Patagonia
IGC Pharma
ACADIA RADIANT
SUVEN CTP3S1502HT6
BIOGEN CELIA
OXA1 Study
Generation HD-2
Active Studies, No Longer Recruiting
Sorry, we couldn't find any posts. Please try a different search.
Past Studies
Giving Opportunities
The DNRC is funded through industry grants and clinical trial contracts, foundations, and community donations. Funds support need-based deserving initiatives related to the diagnosis and treatment of neurological disorders in patients from around the Western New York region.
Corporate or individual donors are welcome to designate their contribution to a specific specialty fund or have it applied to the general operating needs where it is most effective. Gifts can be made in many forms, including cash donations, proceeds from community benefits, corporate contributions and matching gifts, grants, planned gifts, gifts of honor or memorials, and more.
Please contact Maria Caserta, mcaserta@dentinstitute.com, to find out more about how you can help support our mission to bring the most comprehensive treatments to our neighbors and their families suffering with neurological disorders.
DNRC Leadership
Michelle Rainka, PharmD, BCPP, CCRP, President
Clinical Pharmacist, Dent Neurologic Institute
Adjunct Instructor in the School of Pharmacy, SUNY at Buffalo
Laszlo Mechtler, MD, FAAN, FEAN, FASN, FAHS, Chief Medical Officer – Neurology/Oncology
Chief Medical Officer, Dent Neurologic Institute
Chief of Neuro-Oncology, Roswell Park Comprehensive Cancer Center
Professor of Neurology, Oncology, & Neurosurgery, SUNY at Buffalo
Numerous other Board and Advisory Board appointments
Horacio Capote, MD, LFAPA, FASAM, Chief Medical Officer – Psychiatry
Medical Director of Neuropsychiatry, Dent Neurologic Institute
Fran Gengo, PharmD, FCP, Chief Science Officer
Director of Neuropharmacology, Dent Neurologic Institute
Associate Professor of Pharmacy & Neurology, SUNY at Buffalo
Clinical Assistant Professor of Neurosurgery, SUNY at Buffalo
Traci Aladeen, PharmD, BCPP, Secretary
Clinical Pharmacist, Dent Neurologic Institute
Adjunct Instructor in the School of Pharmacy, SUNY at Buffalo
Member, Erie County Department of Mental Health PASSS
Chris Ralyea, Jr, MBA, Treasurer
Chief of Staff, Dent Neurologic Institute
Director of Cannabis Research, Dent Neurologic Institute
Numerous other Board and Advisory Board appointments
Anthony Baynes, Director – At Large
Chairman, AJ Baynes Group
Numerous other Board and Advisory Board appointments
Chet Gary, DDS, JD, Director – At Large
Clinical Assistant Professor of Restorative Dentistry, University at Buffalo School of Dental Medicine
Christine Mann, MBA, Director – At Large
Chief Commercial Officer, Dent Neurologic Institute
Managing Partner, NeuroNet GPO
Managing Director, CareNet
Numerous other Board and Advisory Board appointments
Michael Songin, CPA, CVA, CGMA, Director – At Large
Managing Partner, Songin, Luderman, Maciejewski & Meyer CPAs
Raul Vazquez, MD, Director – At Large
Chief Executive Officer, GBUCBO
Numerous other Board and Advisory Board appointments
Learn about your disorder
DENT provides the highest quality and compassionate patient care to the Western New York region, the direct result of a tireless commitment to staying on the forefront of medical advances and breakthrough technology.
